Cognition Therapeutics Launches Neuroscience Thought Leader Conversations Podcast/Webinar Series

November 21, 2022

https://www.globenewswire.com/news-release/2022/11/21/2559854/0/en/Cognition-Therapeutics-Launches-Neuroscience-Thought-Leader-Conversations-Podcast-Webinar-Series.html

PURCHASE, N.Y., Nov. 21, 2022 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (Nasdaq:CGTX), (the “Company” or “Cognition”) has introduced a new podcast/webinar series named “Conversations,” that will feature virtual fireside chats with neuroscience experts to discuss advances in the research and treatment of Alzheimer’s disease, dementia with Lewy bodies (DLB), and other age-related neurodegenerative conditions.

Read more at globenewswire.com

Related news for (CGTX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.